Pharvaris (PHVS) analyst forecast and price target
Analyst forecast
Consensus of 15 analyst ratings
Based on 5 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Guggenheim | Maintained | Buy | $40.00 from $39.00 | Aug 13, 2026 |
| RBC Capital | Maintained | Outperform | $52.00 from $51.00 | Aug 13, 2026 |
| Citizens | Maintained | Market Outperform | $75.00 from $74.00 | Aug 13, 2026 |
| Wells Fargo | Initiated Coverage | Overweight | $55.00 | Jul 15, 2026 |
| Morgan Stanley | Maintained | Overweight | $46.00 from $41.00 | Jun 25, 2026 |
| Citizens | Maintained | Market Outperform | $74.00 from $75.00 | May 13, 2026 |
| Wolfe Research | Initiated Coverage | Outperform | $42.00 | Apr 9, 2026 |
| Wedbush | Maintained | Outperform | $42.00 from $41.00 | Apr 7, 2026 |
| RBC Capital | Maintained | Outperform | $51.00 from $52.00 | Apr 6, 2026 |
| RBC Capital | Initiated Coverage | Outperform | $52.00 | Mar 9, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $60.00 | Mar 3, 2026 |
| B of A Securities | Maintained | Neutral | $30.00 from $27.00 | Dec 4, 2025 |
| Guggenheim | Maintained | Buy | $39.00 from $32.00 | Dec 4, 2025 |
| Morgan Stanley | Maintained | Overweight | $41.00 from $37.00 | Dec 4, 2025 |
| Oppenheimer | Maintained | Outperform | $50.00 from $44.00 | Dec 4, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $60.00 | Dec 3, 2025 |
| Morgan Stanley | Maintained | Overweight | $37.00 from $34.00 | Nov 14, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $60.00 | Nov 13, 2025 |
| Wedbush | Maintained | Outperform | $30.00 from $27.00 | Nov 13, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $60.00 | Oct 15, 2025 |
Frequently asked questions
What is the price target for PHVS stock?
The average 12-month analyst price target for Pharvaris (PHVS) is $53.60, with a high estimate of $75.00 and a low of $40.00, across 5 analysts.
Is PHVS a buy, sell, or hold?
Analysts covering Pharvaris currently average a Buy rating: 14 buy, 1 hold and 0 sell, from 15 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for PHVS?
The average price target of $53.60 implies 56.77% upside from the last price of $34.19.
What is the latest analyst rating on PHVS?
On Aug 13, 2026, Guggenheim maintained Pharvaris at Buy with a price target of $40.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.